Tara N. Palmore

National Institutes of Health — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

38h-index6.9kcitations167works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Antibiotic Resistance in Bacteria(26), Antibiotic Use and Resistance(22), Bacterial Identification and Susceptibility Testing(18), Vibrio bacteria research studies(13), Infection Control and Ventilation(12)

Publications155 total

Meningoencephalitis Caused by Tick-Borne Encephalitis Virus in a Returning Traveler, United States, 2023
Annals of Internal Medicine Clinical Cases·2025Open Access
Navigating the path forward for evidence-based management of long COVID
Nature Immunology·2025· 1 cited
Infectious Disease Imaging for Global Health
2025
Whole Genome Sequencing Applications in Hospital Epidemiology and Infection Prevention
Current Infectious Disease Reports·2024· 12 citedOpen Access
A retrospective chart review assessing antibiotic treatment of hospitalized patients with discordant <i>Clostridioides difficile</i> assays in an urban hospitalized setting
Antimicrobial Stewardship & Healthcare Epidemiology·2024Open Access
2464. Implementation of a <i>Candida auris</i> admission surveillance protocol at the NIH Clinical Center
Open Forum Infectious Diseases·2023Open Access
2295. Documented SARS-CoV-2 Transmission Events Between Patients and Hospital Staff
Open Forum Infectious Diseases·2023Open Access
2483. Rise in inpatient <i>Candida auris</i> cases at a tertiary hospital in Washington, DC during the COVID-19 pandemic
Open Forum Infectious Diseases·2023Open Access
Asymptomatic screening for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) as an infection prevention measure in healthcare facilities: Challenges and considerations
UNC Libraries·2023Open Access
For Patient Safety, It Is Not Time to Take Off Masks in Health Care Settings
Annals of Internal Medicine·2023· 10 citedOpen Access
Asymptomatic screening for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) as an infection prevention measure in healthcare facilities: Challenges and considerations
Infection Control and Hospital Epidemiology·2022· 50 citedOpen Access
Comparison of Levels of Nasal, Salivary, and Plasma Antibody to Severe Acute Respiratory Syndrome Coronavirus 2 During Natural Infection and After Vaccination
Clinical Infectious Diseases·2022· 29 citedOpen Access
Genomic analysis, immunomodulation and deep phenotyping of patients with nodding syndrome
Brain·2022· 3 citedOpen Access
Annals On Call - Diagnosis and Treatment of Monkeypox Proctitis
Annals of Internal Medicine·2022
Monkeypox Virus–Associated Severe Proctitis Treated With Oral Tecovirimat: A Report of Two Cases
Annals of Internal Medicine·2022· 45 cited
Adding New Fuel to the Fire: Monkeypox in the Time of COVID-19—Implications for Health Care Personnel
Annals of Internal Medicine·2022· 21 citedOpen Access
Prioritizing SARS-CoV-2 testing in a highly immunosuppressed patient population
Antimicrobial Stewardship & Healthcare Epidemiology·2022Open Access
Sharp decline in rates of community respiratory viral detection among patients at the National Institutes of Health Clinical Center during the coronavirus disease 2019 (COVID-19) pandemic
Infection Control and Hospital Epidemiology·2022· 15 citedOpen Access
ICE volume 43 issue 2 Cover and Front matter
Infection Control and Hospital Epidemiology·2022Open Access
Whole Genome Sequencing for Outbreak Investigation
2022
page 1 of 8Next →

Frequent Co-authors

David K. Henderson(12), John P. Dekker(9), Julia A. Segre(8), Anna F. Lau(7), Karen M. Frank(7), Sean Conlan(6), Pamela J. Thomas(5), John H. Powers(5), Anthony F. Suffredini(5), Robert L. Danner(4), Morgan Park(4), Angela V. Michelin(4), Evan S. Snitkin(3), Adrian M. Zelazny(3), Sameer S. Kadri(3), Jennifer Adjemian(3), Yi Ling Lai(3), Emily Ricotta(3), D. Rebecca Prevots(3), Chanu Rhee(3)